Finance

Lists
1477:HKG
Ocumension Therapeutics
4,94 HKD
+1,65%
(+0,080) 1D
16-окт., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1477...
Open
5,00 HKD
High
5,05 HKD
Low
4,90 HKD
Mkt. cap
4,03 млд
Avg. vol.
368,14 миң
Volume
365,50 миң
52-wk high
8,94 HKD
52-wk low
4,04 HKD
EPS
-0,19 HKD
No. of employees
608
Open
5,00 HKD
High
5,05 HKD
Low
4,90 HKD
Mkt. cap
4,03 млд
Avg. vol.
368,14 миң
Volume
365,50 миң
52-wk high
8,94 HKD
52-wk low
4,04 HKD
EPS
-0,19 HKD
No. of employees
608
News stories
From web sources and news partners
About Ocumension Therapeutics
CEO-
Employees608
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
255,16 млн
255,16 млн
211,86 млн
211,86 млн
Cost of goods sold
127,52 млн
127,52 млн
119,10 млн
119,10 млн
Cost of revenue
127,52 млн
127,52 млн
119,10 млн
119,10 млн
Research and development expenses
18,05 млн
18,05 млн
16,40 млн
16,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
121,91 млн
121,91 млн
125,44 млн
125,44 млн
Operating expense
140,33 млн
140,33 млн
142,04 млн
142,04 млн
Total operating expenses
267,85 млн
267,85 млн
261,15 млн
261,15 млн
Operating income
-12,69 млн
-12,69 млн
-49,29 млн
-49,29 млн
Other non operating income
-1,44 млн
-1,44 млн
-252,50 миң
-252,50 миң
EBT including unusual items
-13,22 млн
-13,22 млн
-49,17 млн
-49,17 млн
EBT excluding unusual items
-14,23 млн
-14,23 млн
-50,14 млн
-50,14 млн
Income tax expense
29,00 миң
29,00 миң
333,50 миң
333,50 миң
Effective tax rate
-0,22%
-0,22%
-0,68%
-0,68%
Other operating expenses
-
-
-
-
Net income
-13,25 млн
-13,25 млн
-49,51 млн
-49,51 млн
Net profit margin
-5,19%
-5,19%
-23,37%
-23,37%
Earnings per share
-
-
-
-
Interest and investment income
1,18 млн
1,18 млн
611,50 миң
611,50 миң
Interest expense
-810,50 миң
-810,50 миң
-1,43 млн
-1,43 млн
Net interest expenses
367,50 миң
367,50 миң
-819,00 миң
-819,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
19,94 млн
19,94 млн
-13,14 млн
-13,14 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору